Gilead Sciences set aside $200 million for a potential settlement with federal prosecutors to resolve an investigation into ...
4h
Hosted on MSNThe Handmaid's Tale Sequel Show Casts Its Young Protagonist With A Connection To GileadHulu’s The Testaments casts its Daisy, a Canadian teen whose world is upended when she discovers her hidden connection to ...
The Handmaid’s Tale creator Bruce Miller has reportedly been working on the show for “several years” now, and stepped down as ...
The Testaments, the sequel series to The Handmaid’s Tale, has cast a major leading role. The upcoming series, based on ...
Analysts at RBC Capital Markets have predicted twice-yearly lenacapavir could become a $2 billion product, and become a key ...
Gilead Sciences Inc. closed 0.11% below its 52-week high of $112.11, which the company reached on February 25th.
Hulu confirmed Lucy Halliday will be appearing in The Testaments, The Handmaid's Tale sequel, and she is going to portray Daisy, the role of one of the trio of lead female characters in the series, Va ...
Gilead Sciences' Q4 2024 results, driven by HIV drug demand and Trodelvy growth, make it a compelling choice for long-term ...
13d
GlobalData on MSNGilead’s lenacapavir moves closer to FDA approval for HIV PrEP useLenacapavir is already approved under the name Sunlenca as an HIV treatment for patients resistant to other medication ...
Lucy Halliday (Blue Jean) has been tapped as a lead opposite Chase Infiniti and Ann Dowd in The Handmaid’s Tale sequel The ...
Gilead Sciences has announced that the US Food and Drug Administration (FDA) has accepted its New Drug Application ...
Hulu’s upcoming series “The Testaments,” a sequel to “The Handmaid’s Tale,” has cast Lucy Halliday in the role of Daisy. “The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results